These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11724235)

  • 1. In vitro and in vivo study of two types of long-circulating solid lipid nanoparticles containing paclitaxel.
    Chen DB; Yang TZ; Lu WL; Zhang Q
    Chem Pharm Bull (Tokyo); 2001 Nov; 49(11):1444-7. PubMed ID: 11724235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro and in vivo study of two kinds of long-circulating solid lipid nanoparticles containing paclitaxel].
    Chen DB; Yang TZ; Lu WL; Zhang Q
    Yao Xue Xue Bao; 2002 Jan; 37(1):54-8. PubMed ID: 12579901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes.
    Crosasso P; Ceruti M; Brusa P; Arpicco S; Dosio F; Cattel L
    J Control Release; 2000 Jan; 63(1-2):19-30. PubMed ID: 10640577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and in vitro assessment of paclitaxel loaded lipid nanoparticles formulated using modified solvent injection technique.
    Pandita D; Ahuja A; Velpandian T; Lather V; Dutta T; Khar RK
    Pharmazie; 2009 May; 64(5):301-10. PubMed ID: 19530440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing water-soluble prodrugs of paclitaxel.
    Ceruti M; Crosasso P; Brusa P; Arpicco S; Dosio F; Cattel L
    J Control Release; 2000 Jan; 63(1-2):141-53. PubMed ID: 10640588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and biodistribution of paclitaxel loaded in pegylated solid lipid nanoparticles after intravenous administration.
    Li R; Eun JS; Lee MK
    Arch Pharm Res; 2011 Feb; 34(2):331-7. PubMed ID: 21380818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and characterization of solid lipid nanospheres containing paclitaxel.
    Cavalli R; Caputo O; Gasco MR
    Eur J Pharm Sci; 2000; 10(4):305-9. PubMed ID: 10838020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics, tissue distribution and anti-tumour efficacy of paclitaxel delivered by polyvinylpyrrolidone solid dispersion.
    Liu X; Sun J; Chen X; Wang S; Scott H; Zhang X; Zhang Q
    J Pharm Pharmacol; 2012 Jun; 64(6):775-82. PubMed ID: 22571255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonlinear pharmacokinetics of paclitaxel in mice results from the pharmaceutical vehicle Cremophor EL.
    Sparreboom A; van Tellingen O; Nooijen WJ; Beijnen JH
    Cancer Res; 1996 May; 56(9):2112-5. PubMed ID: 8616858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lactoferrin-appended solid lipid nanoparticles of paclitaxel for effective management of bronchogenic carcinoma.
    Pandey V; Gajbhiye KR; Soni V
    Drug Deliv; 2015 Feb; 22(2):199-205. PubMed ID: 24467582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation, characterization and in vitro cytotoxicity of paclitaxel-loaded sterically stabilized solid lipid nanoparticles.
    Lee MK; Lim SJ; Kim CK
    Biomaterials; 2007 Apr; 28(12):2137-46. PubMed ID: 17257668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paclitaxel and its formulations.
    Singla AK; Garg A; Aggarwal D
    Int J Pharm; 2002 Mar; 235(1-2):179-92. PubMed ID: 11879753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanistic population pharmacokinetics of total and unbound paclitaxel for a new nanodroplet formulation versus Taxol in cancer patients.
    Bulitta JB; Zhao P; Arnold RD; Kessler DR; Daifuku R; Pratt J; Luciano G; Hanauske AR; Gelderblom H; Awada A; Jusko WJ
    Cancer Chemother Pharmacol; 2009 May; 63(6):1049-63. PubMed ID: 18791718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and characterization of solid lipid nanoparticles containing silibinin.
    Zhang JQ; Liu J; Li XL; Jasti BR
    Drug Deliv; 2007 Aug; 14(6):381-7. PubMed ID: 17701527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum-stable, long-circulating paclitaxel-loaded colloidal carriers decorated with a new amphiphilic PEG derivative.
    Basile L; Passirani C; Huynh NT; Béjaud J; Benoit JP; Puglisi G; Pignatello R
    Int J Pharm; 2012 Apr; 426(1-2):231-238. PubMed ID: 22306040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular uptake of solid lipid nanoparticles and cytotoxicity of encapsulated paclitaxel in A549 cancer cells.
    Yuan H; Miao J; Du YZ; You J; Hu FQ; Zeng S
    Int J Pharm; 2008 Feb; 348(1-2):137-45. PubMed ID: 17714896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In situ rat intestine absorption of paclitaxel-loaded solid lipid nanoparticles modified with cell-penetrating peptides].
    Li CC; Zhang ZH; Zhang YL; Lü HX; Zhou JP
    Yao Xue Xue Bao; 2013 Jan; 48(1):131-7. PubMed ID: 23600154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation and pharmacokinetic evaluation of a paclitaxel nanosuspension for intravenous delivery.
    Wang Y; Li X; Wang L; Xu Y; Cheng X; Wei P
    Int J Nanomedicine; 2011; 6():1497-507. PubMed ID: 21796250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular uptake and antitumour activity of paclitaxel incorporated into trilaurin-based solid lipid nanoparticles in ovarian cancer.
    Xu W; Lim SJ; Lee MK
    J Microencapsul; 2013; 30(8):755-61. PubMed ID: 23594306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and evaluation of Cremophor-free paclitaxel solid dispersion by a supercritical antisolvent process.
    Park JH; Yan YD; Chi SC; Hwang DH; Shanmugam S; Lyoo WS; Woo JS; Yong CS; Choi HG
    J Pharm Pharmacol; 2011 Apr; 63(4):491-9. PubMed ID: 21401600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.